This paper is in the following e-collection/theme issue:

Theme issue 2021: Outbreaks and Public Health Surveillance research in the Eastern Mediterranean Region (23) Outbreak and Pandemic Preparedness and Management (1743) Infectious Diseases (non-STD/STI) (1592) Innovative Methods in Public Health and Surveillance (336) Hygiene and Infection Prevention (325) JMIR Theme Issue: COVID-19 Special Issue (2461) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520)

Published on in Vol 7, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27609, first published .
Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome

Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome

Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome

Authors of this article:

Sabahat Ali1 Author Orcid Image ;   Sundas Khalid2 Author Orcid Image ;   Maham Afridi3 Author Orcid Image ;   Samar Akhtar4 Author Orcid Image ;   Yousef S Khader5 Author Orcid Image ;   Hashaam Akhtar4 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.